Audientes CEO: We have the perfect product for the future OTC channel

Hearing aid firm Audientes is seeing dollar signs on the future OTC market for hearing aids in the US. For this reason, the firm is now doing everything in its power to get low-cost hearing aids approved by the US Food and Drug Administration.
Audientes CEO Steen Thygesen | Photo: Audientes / PR
Audientes CEO Steen Thygesen | Photo: Audientes / PR

The US is undoubtably the largest single market in the hearing industry, and when the new regulation on over-the-counter sales of hearing aids is implemented, probably in a few years' time, sales will blossom for the companies that are selling low-cost hearing devices.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading